Online citations, reference lists, and bibliographies.
← Back to Search

Description And Characterization Of The Novel Hyperthermia- And Thermoablation-system MFH 300F For Clinical Magnetic Fluid Hyperthermia.

U. Gneveckow, Andreas Jordan, R. Scholz, Volker Brüss, N. Waldoefner, J. Ricke, A. Feussner, B. Hildebrandt, B. Rau, P. Wust
Published 2004 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Magnetic fluid hyperthermia (MFH) is a new approach to deposit heat power in deep tissues by overcoming limitations of conventional heat treatments. After infiltration of the target tissue with nanosized magnetic particles, the power of an alternating magnetic field is transformed into heat. The combination of the 100 kHz magnetic field applicator MFH 300F and the magnetofluid (MF), which both are designed for medical use, is investigated with respect to its dosage recommendations and clinical applicability. We found a magnetic field strength of up to 18 kA/m in a cylindrical treatment area of 20 cm diameter and aperture height up to 300 mm. The specific absorption rate (SAR) can be controlled directly by the magnetic field strength during the treatment. The relationship between magnetic field strength and the iron normalized SAR (SAR(Fe)) is only slightly depending on the concentration of the MF and can be used for planning the target SAR. The achievable energy absorption rates of the MF distributed in the tissue is sufficient for either hyperthermia or thermoablation. The fluid has a visible contrast in therapeutic concentrations on a CT scanner and can be detected down to 0.01 g/l Fe in the MRI. The system has proved its capability and practicability for heat treatment in deep regions of the human body.
This paper references
10.1016/S0304-8853(98)00558-7
Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro
A. Jordan (1999)
10.1016/S1470-2045(02)00801-X
Real-time tumour imaging
M. Habeck (2002)
10.1080/02656730150502323
Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations.
W. Tilly (2001)
10.1080/02656730110091919
The Dutch Deep Hyperthermia Trial: results in cervical cancer
J. Zee (2002)
10.3109/02656739509022453
Clinical, physiological and anatomical determinants for radiofrequency hyperthermia.
P. Wust (1995)
10.1016/S0140-6736(95)90463-8
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
J. Overgaard (1995)
10.1016/0360-3016(96)00154-X
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.
C. Vernon (1996)
10.1007/978-3-642-57858-8
Thermoradiotherapy and Thermochemotherapy
M. Seegenschmiedt (1995)
10.1016/0360-3016(95)02151-5
Local hyperthermia of N2/N3 cervical lymph node metastases: correlationof technical/thermal parameters and response.
P. Wust (1996)
10.3109/02656739709023559
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
A. Jordan (1997)
10.1016/S0304-8853(02)00706-0
Heating magnetic fluid with alternating magnetic field
R. E. Rosensweig (2002)
10.1136/gut.50.5.733
Ablative therapy for liver tumours
E. Dick (2002)
10.1016/S1470-2045(02)00818-5
Hyperthermia in combined treatment of cancer.
P. Wust (2002)
Brachytherapy and hyperthermia for malignant astrocytomas.
P. Sneed (1994)
10.1016/S0090-4295(02)01653-9
Interstitial thermal therapy in patients with localized prostate cancer: histologic analysis.
R. Tucker (2002)
10.3109/02656739609027678
Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.
A. Jordan (1996)



This paper is referenced by
10.1016/J.COLSURFA.2010.09.011
Nanosized magnetofluorescent Fe3O4-curcumin conjugate for multimodal monitoring and drug targeting
L. Tran (2010)
10.1039/c2nr30667k
New insights into the heating mechanisms and self-regulating abilities of manganite perovskite nanoparticles suitable for magnetic fluid hyperthermia.
E. Natividad (2012)
10.1088/0022-3727/46/12/125006
Structural and magnetic study of zinc-doped magnetite nanoparticles and ferrofluids for hyperthermia applications
P. Zelis (2013)
10.1201/B15274-40
Nanotechnology: Applications to Pediatric Neurosurgery
Giancarlo Suffredini (2013)
10.1371/journal.pone.0081227
Analysis of the Distribution of Magnetic Fluid inside Tumors by a Giant Magnetoresistance Probe
C. Gooneratne (2013)
10.2217/17435889.3.3.321
A carbon-wrapped nanoscaled thermometer for temperature control in biological environments.
A. Vyalikh (2008)
10.1080/01457630902854371
Hyperthermia and Cancer Treatment
N. Saniei (2009)
10.1016/j.actbio.2009.07.004
Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy.
S. Purushotham (2010)
10.2217/nnm.09.96
Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy.
Meng Lin (2010)
10.3109/02656730903183445
Hyperthermia classic commentary: ‘Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia’ by Andreas Jordan et al., International Journal of Hyperthermia, 1993;9:51–68.
A. Jordan (2009)
10.1080/02656736.2016.1195018
Mitigation of eddy current heating during magnetic nanoparticle hyperthermia therapy
Robert V Stigliano (2016)
10.1063/1.4960406
Hyperthermia with rotating magnetic nanowires inducing heat into tumor by fluid friction
P. Egolf (2016)
10.1007/978-94-007-1248-5_20
Nanoparticles Enhanced Hyperthermia
Q. Wang (2011)
10.1002/mrm.25181
Quantifying iron‐oxide nanoparticles at high concentration based on longitudinal relaxation using a three‐dimensional SWIFT look‐locker sequence
Jinjin Zhang (2014)
Remote Sensing of the Temperature during Magnetic Hyperthermia
F. Lin (2020)
10.1016/J.MATCHEMPHYS.2019.03.032
Surfactant-free synthesis and magnetic hyperthermia investigation of iron oxide (Fe3O4) nanoparticles at different reaction temperatures
Ahmad Reza Yasemian (2019)
10.1080/02656730500331868
Evolving technology for thermal therapy of cancer
P. Stauffer (2005)
10.1039/C3NJ00554B
Studies on colloidal stability of PVP-coated LSMO nanoparticles for magnetic fluid hyperthermia
S. Jadhav (2013)
10.1109/TNB.2008.2011864
Development of Superparamagnetic Iron Oxide Nanoparticles (SPIONS) for Translation to Clinical Applications
Meng Meng Lin (2008)
10.3109/02656736.2015.1119316
Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia
A. LeBrun (2016)
10.1016/j.jim.2010.02.009
Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells.
H. Schreiber (2010)
10.1088/1361-6463/AA77E9
Heating efficiency and correlation between the structural and magnetic properties of oleic acid coated MnFe2O4 nanoparticles for magnetic hyperthermia application
R. Raland (2017)
10.1002/9781119127420.CH29
Magnetic Nanoparticle Hyperthermia in Cancer Treatment: History, Mechanism, Imaging‐Assisted Protocol Design, and Challenges
A. LeBrun (2018)
10.1109/ACCESS.2019.2926793
Design and Control of Field-Free Region Using Two Permanent Magnets for Selective Magnetic Hyperthermia
Armando Ramos Sebastian (2019)
10.2217/nnm.14.106
Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.
T. Kobayashi (2014)
10.1007/978-1-59745-225-0_23
Regional Therapy of Brain Tumors
A. Jordan (2007)
10.1080/02656736.2016.1216183
A novel strategy combining magnetic particle hyperthermia pulses with enhanced performance binary ferrite carriers for effective in vitro manipulation of primary human osteogenic sarcoma cells
A. Makridis (2016)
10.1016/j.nano.2009.01.011
Magnetic fluid hyperthermia therapy for malignant brain tumors--an ethical discussion.
S. Mueller (2009)
10.1109/TMAG.2009.2019128
Three-Dimensional Model for Determining Inhomogeneous Thermal Dosage in a Liver Tumor During Arterial Embolization Hyperthermia Incorporating Magnetic Nanoparticles
Ruizhi Xu (2009)
10.1088/0957-4484/18/34/345101
Protein and polymer immobilized La0.7Sr0.3MnO3 nanoparticles for possible biomedical applications
K. R. Bhayani (2007)
Evaluation of nanoparticles-based thermotherapy for cancer
Edwina Wiryaatmadja (2007)
10.1007/s11060-010-0389-0
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
K. Maier-Hauff (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar